CEO (Chief Executive Officer) since 2001
Partner/Owner since 1990
Representative before the EPO

Employment test 51 - 200 employees
Company dna potter clarkson llp
operating since 1889
Headquarter in Nottingham and 1 office
active in Legal Services, IP Consulting, and IP Portfolio Processing

Richard Bassett has worked on the following 18 EPO patent applications which have been published in the last five years:

EP11712426

MECHANICALLY COMPETENT SCAFFOLD FOR ROTATOR CUFF AND TENDON AUGMENTATION

IPC classification:
A61B 17/11, A61F 2/08
Agent:
Richard Bassett, Potter Clarkson LLP
Status:
EXAMINATION IN PROGRESS
EP12770817

SELECTIVE CYSTEINE PROTEASE INHIBITORS AND USES THEREOF

IPC classification:
C07K 5/00, C07K 5/02, C07K 5/06, C07K 5/08, C07K 7/06
Agent:
Richard Bassett, Potter Clarkson LLP
Status:
EXAMINATION IN PROGRESS
EP12785983

PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS RESISTANT ANIMALS

IPC classification:
A01K 67/027, C12N 15/00
Applicant:
The Curators Of The University Of Missouri
Agent:
Richard Bassett, Potter Clarkson LLP
Status:
EXAMINATION IN PROGRESS
EP12725992

THERAPEUTIC PROTEINS WITH INCREASED HALF-LIFE AND METHODS OF PREPARING SAME

IPC classification:
A61K 38/38, A61K 38/55, A61K 47/48
Applicant:
Baxter International Inc
Applicant:
Baxter Healthcare SA
Applicant:
Baxalta Incorporated
Applicant:
Baxalta GmbH
Agent:
Richard Bassett, Potter Clarkson LLP
Status:
GRANT OF PATENT INTENDED
EP12728887

MODIFIED ALGINATES FOR CELL ENCAPSULATION AND CELL THERAPY

IPC classification:
A61K 47/00, C08B 37/00, C40B 50/00
Applicant:
Massachusetts Institute of Technology (MIT) Inc.
Agent:
Richard Bassett, Potter Clarkson LLP
Status:
GRANT OF PATENT INTENDED
EP12728341

BIOADHESIVE DRUG DELIVERY COMPOSITIONS

IPC classification:
A61K 9/48
Agent:
Richard Bassett, Potter Clarkson LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12731234

SYNTHESIS AND CHARACTERIZATION OF SECOND GENERATION BENZOFURANONE RING SUBSTITUTED NOSCAPINE ANALOGS

IPC classification:
A61K 31/4355, A61P 35/00, C07D 491/04
Applicant:
Georgia State University Research Foundation, Inc.
Agent:
Richard Bassett, Potter Clarkson LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12815580

CARBOCYANINES FOR G-QUADRUPLEX DNA STABILIZATION AND TELOMERASE INHIBITION

IPC classification:
C12Q 1/68
Applicant:
Georgia State University Research Foundation, Inc.
Agent:
Richard Bassett, Potter Clarkson LLP
Status:
EXAMINATION IN PROGRESS
EP12804123

METHOD FOR CONVERTING AND PRODUCING CARBONATE MINERALS FROM CARBON DIOXIDE USING RECOMBINANT BIOCATALYST

IPC classification:
C12N 9/88, C12P 3/00
Applicant:
Postech Academy-Industry Foundation
Agent:
Richard Bassett, Potter Clarkson LLP
Status:
EXAMINATION IN PROGRESS
EP11701319

BIOMATRICES TO ATTRACT AND RETAIN REGENERATIVE AND REPARATIVE CELLS

IPC classification:
A61K 38/18, A61K 47/42, A61L 24/10, A61P 9/10
Applicant:
Baxter International Inc
Applicant:
Baxter Healthcare SA
Agent:
Richard Bassett, Potter Clarkson LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15171701

CROSSLINKED CATION EXCHANGE POLYMERS, COMPOSITIONS AND USE IN TREATING HYPERKALEMIA

IPC classification:
A61K 31/74, A61P 1/00
Agent:
Richard Bassett, Potter Clarkson LLP
Agent:
Eisenführ Speiser & Partner Patentanwälte Rechtsanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP13156622

Treatment of bladder dysfunction using liposomal botulinum toxin

IPC classification:
A61K 9/127, A61K 38/48, A61P 13/10
Agent:
Richard Bassett, Potter Clarkson LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12179740

IVIG modulation of chemokines for treatment of Multiple Sclerosis, Alzheimer's disease, and Parkinson's disease

IPC classification:
C12Q 1/68
Applicant:
Baxter International Inc
Applicant:
Baxter Healthcare SA
Agent:
Richard Bassett, Potter Clarkson LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12179736

IVIG modulation of chemokines for treatment of Multiple Sclerosis, Alzheimer's disease, and Parkinson's disease

IPC classification:
C12Q 1/68
Applicant:
Baxter International Inc
Applicant:
Baxter Healthcare SA
Agent:
Richard Bassett, Potter Clarkson LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12179743

IVIG modulation of chemokines for treatment of Multiple Sclerosis, Alzheimer's disease, and Parkinson's disease

IPC classification:
C12Q 1/68
Applicant:
Baxter International Inc
Applicant:
Baxter Healthcare SA
Agent:
Richard Bassett, Potter Clarkson LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12179739

IVIG modulation of chemokines for treatment of Multiple Sclerosis, Alzheimer's disease, and Parkinson's disease

IPC classification:
C12Q 1/68
Applicant:
Baxter International Inc
Applicant:
Baxter Healthcare SA
Agent:
Richard Bassett, Potter Clarkson LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11763407

INJECTABLE DENDRIMER HYDROGEL NANOPARTICLES

IPC classification:
A61K 47/48, A61P 25/28, A61P 31/00, C08G 73/02, C08L 79/02
Applicant:
Wayne State University
Agent:
Richard Bassett, Potter Clarkson LLP
Agent:
Multiple attorneys, Withers & Rogers LLP
Status:
GRANT OF PATENT INTENDED
EP12196176

Compositions for prevention of adhesions and other barrier applications

IPC classification:
A61K 38/10, A61L 15/42, A61L 26/00
Agent:
Richard Bassett, Potter Clarkson LLP
Status:
The patent has been granted

Please Sign in to use this feature